This compound is a pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients (APIs). It features a piperazine ring and a chlorophenyl-substituted cyclohexene core, giving it moderate lipophilicity and a single hydrogen-bond donor.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1228780-72-0
1-((4'-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine dihydrochloride
pharmaceutical intermediate
O-Benzylglycine toluene-p-sulphonate
pharmaceutical intermediate for API synthesis
4-(4-Chlorobutyl)pyridine hydrochloride
pharmaceutical intermediate for API synthesis
4-(Benzyloxycarbonyl)phenylboronic acid
pharmaceutical intermediate for API synthesis
Benzyl (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo-(2,3-e)pyrazin-8-yl)pyrrolidine-1-carboxylate
pharmaceutical intermediate for API synthesis
Ru(Me-allyl)2(COD)
Pharmaceutical intermediate for ruthenium complexes
6-bromopyridine-2-carbonitrile
pharmaceutical intermediate
(R)-methyl 4-((3R,5S,10S,13R,17R)-10,13-dimethyl-7-oxo-3-(tetrahydro-2H-pyran-2-yloxy)-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
Pharmaceutical intermediate for steroid synthesis
1-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazine
YCNNHDUZLQPKJY-UHFFFAOYSA-N
CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCNCC3)C
—